What's in HALEON US HOLDINGS's pipeline?

HALEON US HOLDINGS has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with HALEON US HOLDINGS's portfolio?

Top competitors by shared drug class: UMC Utrecht, , Harrow Health, Pfizer, ANI Pharmaceuticals.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/haleon-us-holdings.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

HALEON US HOLDINGS — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HALEON US HOLDINGS pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Arnuity Ellipta	FLUTICASONE FUROATE	marketed	Corticosteroid	Glucocorticoid receptor	Respiratory	2007-01-01
Excedrin Extra Strength Pain Reliever	NSAID	marketed	Nonsteroidal Anti-inflammatory Drug [EPC]	Cyclooxygenase	Immunology	2004-01-01

Therapeutic area mix

Immunology · 1
Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

UMC Utrecht · 2 shared drug classes
· 2 shared drug classes
Harrow Health · 2 shared drug classes
Pfizer · 2 shared drug classes
ANI Pharmaceuticals · 2 shared drug classes
University of Utah · 2 shared drug classes
Aramis Biosciences, Inc. · 1 shared drug class
Allergan · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for HALEON US HOLDINGS:

Cite this brief

Drug Landscape (2026). HALEON US HOLDINGS — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/haleon-us-holdings. Accessed 2026-05-16.